Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-26
1995-02-07
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514595, 514622, 546332, 546337, 564 47, 564171, C07D21340, C07C23526, C07C27524, C07C 5746
Patent
active
053875958
ABSTRACT:
Substituted alicyclic compounds of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, and asthma.
REFERENCES:
patent: 3506673 (1970-04-01), Warawa et al.
patent: 3574165 (1971-04-01), Braus et al.
patent: 4804661 (1989-02-01), Ferrine et al.
patent: 4943578 (1990-07-01), Naylor et al.
patent: 5064838 (1991-11-01), Carr et al.
J. Clin. Invest., 74, 1532-1539 (1984), Payan, et al.
Life Sci., 49, 1941-1953 (1991), Frossard, et al.
Life Sci., 50, PL-101-PL-106(1992), Emonds-Alt, et al.
J. Med. Chem. 35, 2591-2600 (1992), Lowe, et al.
Biochem. & Biophys. Res. Comm., 184(3), 1418-1424 (1992), Advenier, et al.
Biorg. & Med. Chem. Lett., 2(1), 37-40 (1992), Peyronel et al.
Biorg. & Med. Chem. Lett., 2(6), 559-64 (1992), Howson, et al.
Drug New Perspect., 5(4) 223-228 (1992), Lowe, et al.
Finke Paul E.
Maccoss Malcolm
Miller Daniel J.
Mills Sander G.
Underwood Dennis J.
Davis Zinna N.
Ivy C. Warren
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Alicyclic compounds as tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alicyclic compounds as tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alicyclic compounds as tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1110567